Table 1.
Demographic and Clinical Characteristics.
| GS with GD | GS | Ref. Range | |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Age | 34.3 ± 13.6 | 29.1 ± 11.2 | |
| Gender n(M/F) | 103/3 | 1012/38 | |
| BMI | 20.75 ± 2.95 | 22.04 ± 3.72 | |
| Total Bilirubin (mmol/L) | 3.67 ± 1.92 | 3.8 ± 1.8 | 0.3–1.2 |
| Direct Bilirubin (mmol/L) | 0.70 ± 0.63 | 0.9 ± 0.4 | Up to 0.2 |
| Indirect Bilirubin (mmol/L) | 2.97 ± 1.68 | 2.9 ± 1.7 | |
| ALT (U/L) | 33.97 ± 18.08 | 31.6 ± 19.3 | 0–40 |
| AST (U/L) | 30.17 ± 10.49 | 29.5 ± 16.4 | Up to 40 |
| ALP (U/L) | 82.91 ± 27.97 | 84.2 ± 28.7 | 30–120 |
| Total protein (mmol/L) | 7.35 ± 0.58 | 7.6 ± 0.4* | 6–8 |
| Albumin (mmol/L) | 4.29 ± 0.67 | 4.6 ± 0.3* | 3.5–5.2 |
| Globulin (mmol/L) | 3.01 ± 0.42 | 3.0 ± 0.3 | 2.3–3.5 |
| Total WBC (cell/mm3) | 7807.61 ± 2831.04 | 7679.4 ± 2467.1 | 4000–10000 |
| RBC (millions/mm3) | 4.50 ± 0.93 | 4.9 ± 1.0* | 3.8–4.8 |
| Hemoglobin (mmol/L) | 13.51 ± 2.46 | 14.6 ± 2.6* | 12.0–15.0 |
| HCT (%) | 39.24 ± 6.65 | 41.7 ± 8.5* | 36–46 |
| Platelets (×106/mm3) | 1.93 ± 0.76 | 2.4 ± 0.7* | 1.5–4.1 |
GS, Gilbert's syndrome; GD, gallstone disease; Ref, reference; BMI, body mass index; ALT, alanine transaminase; AST, aspartate amino transferase; ALP, alkaline phosphatase; WBC, white blood cells; RBC, red blood cells; HCT, hematocrit.
*
P > 0.05.